SynthesisThe Cochrane database of systematic reviews2022

Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

Kim Boesen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.